top of page
Curenetics
Is developing an AI-based tool to predict patient response to immunotherapies and optimise therapeutic decisions. By combining genomics, imaging and clinical data, its platform offers personalized recommendations, improving the effectiveness of treatments while reducing adverse effects and costs.
PSCC's entrance
Décembre 2025
Localization
UK - Londres
Modality
DM/DiV
Development status
Medtech - Development
Lauréat (s)
bottom of page



